Oligostim Zinc - Copper | 40 Sublingual Tablets Granions

Hormonal Balance Support – For Ages 12 and Up

Who is it for?
✔ Teenagers (12+)
✔ Adults
✖ Not recommended during pregnancy or breastfeeding

Product Type: Sublingual Tablets

Description:
Oligostim Zinc - Copper is a trace element-based medicine designed to support hormonal balance during key transitional phases such as puberty, premenstrual syndrome (PMS), and menopause. Recommended for adolescents over 12 and adults, this formulation helps regulate functional hormonal imbalances by modifying the body's internal terrain.

Each tablet contains:

• Zinc Gluconate (0.220 mg)

• Copper Gluconate (0.220 mg)

These essential trace elements work synergistically to help support hormonal and metabolic regulation.

Directions for Use:

• Take 1 to 2 tablets per day

• Allow to dissolve slowly under the tongue

• Preferably taken in the morning or away from meals

Always follow your healthcare provider’s instructions before starting this treatment.

Warnings & Precautions:

• Do not use if you are allergic to any of the ingredients.

• Not suitable for children under 12 years of age.

• Contraindicated in cases of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.

• Not recommended during pregnancy or breastfeeding without medical advice.

• Store at room temperature and keep out of reach of children.

• Do not use past the expiration date indicated on the packaging.

Pack Size:
Tube of 40 sublingual tablets

Please read the following full disclosure before taking or using this product.

SUMMARY OF PRODUCT CHARACTERISTICS

ANSM – Updated on: 01/08/2023

1. NAME OF THE MEDICINAL PRODUCT

OLIGOSTIM ZINC COPPER, sublingual tablet

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

• Zinc gluconate: 0.220 mg

  • Equivalent elemental zinc: 0.032 mg

• Copper gluconate: 0.220 mg

  • Equivalent elemental copper: 0.031 mg

Per sublingual tablet.

Excipient with known effect: lactose.
For the full list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Sublingual tablet.

4. CLINICAL PARTICULARS

4.1. Therapeutic Indications

Used as a terrain modifier, particularly in cases of functional disorders during:

• puberty (in children over 12),

• menopause,

• and premenstrual syndrome.

4.2. Posology and Method of Administration

FOR ADULTS AND CHILDREN OVER 12 YEARS OLD ONLY.
Oral route.
Take 1 to 2 tablets daily, allow to dissolve under the tongue, preferably in the morning on an empty stomach or away from meals.

4.3. Contraindications

Contraindicated in cases of hypersensitivity to any of the ingredients.

4.4. Special Warnings and Precautions for Use

This trace element treatment does not replace any necessary specific treatment.
This product contains lactose and is not recommended for patients with:

• galactose intolerance,

• Lapp lactase deficiency, or

• glucose-galactose malabsorption syndrome (rare hereditary conditions).

4.5. Interactions with Other Medicinal Products

No clinically significant interactions are known to date.

4.6. Fertility, Pregnancy, and Lactation

Due to lack of clinical and experimental data, use during pregnancy or breastfeeding is not recommended as a precaution.

4.7. Effects on Ability to Drive and Use Machines

Not applicable.

4.8. Undesirable Effects

None reported.

Reporting of Suspected Adverse Reactions
Reporting suspected adverse reactions after marketing authorization is important. It enables continued monitoring of the benefit-risk balance. Healthcare professionals should report any suspected adverse reactions via the national reporting system:
www.signalement-sante.gouv.fr

4.9. Overdose

No cases of overdose have been reported.

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmacodynamic Properties

Pharmacotherapeutic group: OLIGOTHERAPY (V: Various)
Trace mineral element.

5.2. Pharmacokinetic Properties

Not provided.

5.3. Preclinical Safety Data

Not provided.

6. PHARMACEUTICAL PARTICULARS

6.1. List of Excipients

• Lactose

• Croscarmellose A

• Magnesium stearate

6.2. Incompatibilities

Not applicable.

6.3. Shelf Life

5 years

6.4. Special Precautions for Storage

Store at room temperature.

6.5. Nature and Contents of Container

Polypropylene tube containing 40 sublingual tablets.

6.6. Special Precautions for Disposal and Handling

No special requirements.

7. MARKETING AUTHORISATION HOLDER

LABORATOIRE DES GRANIONS
Le Parador II
5 Allée Crovetto Frères
98000 Monaco

8. MARKETING AUTHORISATION NUMBER(S)

• 34009 333 601 9 1: 40 sublingual tablets in a polypropylene tube.

9. DATE OF FIRST AUTHORISATION/RENEWAL

[To be completed later by the holder]

10. DATE OF TEXT REVISION

[To be completed later by the holder]

11. RADIATION DOSIMETRY

Not applicable.

12. INSTRUCTIONS FOR RADIOPHARMACEUTICAL PREPARATION

Not applicable.

PRESCRIPTION AND DISPENSING CONDITIONS

Medicine not subject to medical prescription.